4D Molecular Therapeutics Inc (FDMT) — Free Cash Flow Generation Index

Latest as of December 2025: 0.98x

4D Molecular Therapeutics Inc (FDMT) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of $27.92 Million represents 1% of operating cash flow ($28.55 Million). See 4D Molecular Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

$27.92 Million

USD

Operating Cash Flow

$28.55 Million

USD

Capital Expenditures

$631.00K

USD

4D Molecular Therapeutics Inc Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for 4D Molecular Therapeutics Inc across 1 annual periods. Explore 4D Molecular Therapeutics Inc (FDMT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for 4D Molecular Therapeutics Inc (2017–2017)

Year-by-year Free Cash Flow Generation Index for 4D Molecular Therapeutics Inc. For the full company profile including market capitalisation, see 4D Molecular Therapeutics Inc stock valuation.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2017	0.93x	$7.66 Million	$8.24 Million	$573.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).